Multiple Sclerosis Market Report

Global and Region Multiple Sclerosis Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：200
  • REPORT CODE：GMM921733
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Multiple Sclerosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Multiple Sclerosismarket, defines the market attractiveness level of Multiple Sclerosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Multiple Sclerosis industry, describes the types of Multiple Sclerosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Multiple Sclerosis market and the development prospects and opportunities of Multiple Sclerosis industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Multiple Sclerosis market in Chapter 13.

    By Player:

    • Teva

    • GlaxoSmithKline

    • Novartis

    • Biogen

    • Bayer HealthCare

    • Acorda Therapeutics

    • Abbvie

    • Merck Serono

    • Pfizer

    • Genzyme (Sanofi)

    By Type:

    • Injectable agents

    • Oral agents

    By End-User:

    • Hosptial

    • Research

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Multiple Sclerosis Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Multiple Sclerosis Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Multiple Sclerosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Multiple Sclerosis Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Multiple Sclerosis Market Analysis and Outlook to 2022

    • 7.1 Global Multiple Sclerosis Consumption (2017-2022)

    • 7.2 United States Multiple Sclerosis Consumption (2017-2022)

    • 7.3 Europe Multiple Sclerosis Consumption (2017-2022)

    • 7.4 China Multiple Sclerosis Consumption (2017-2022)

    • 7.5 Japan Multiple Sclerosis Consumption (2017-2022)

    • 7.6 India Multiple Sclerosis Consumption (2017-2022)

    • 7.7 South Korea Multiple Sclerosis Consumption (2017-2022)

    8 Region and Country-wise Multiple Sclerosis Market Analysis and Outlook to 2028

    • 8.1 Global Multiple Sclerosis Consumption Forecast (2022-2028)

    • 8.2 United States Multiple Sclerosis Consumption Forecast (2022-2028)

    • 8.3 Europe Multiple Sclerosis Consumption Forecast (2022-2028)

    • 8.4 China Multiple Sclerosis Consumption Forecast (2022-2028)

    • 8.5 Japan Multiple Sclerosis Consumption Forecast (2022-2028)

    • 8.6 India Multiple Sclerosis Consumption Forecast (2022-2028)

    • 8.7 South Korea Multiple Sclerosis Consumption Forecast (2022-2028)

    9 Global Multiple Sclerosis Market Outlook by Types and Applications to 2022

    • 9.1 Global Multiple Sclerosis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Injectable agents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oral agents Consumption and Growth Rate (2017-2022)

    • 9.2 Global Multiple Sclerosis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hosptial Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Consumption and Growth Rate (2017-2022)

    10 Global Multiple Sclerosis Market Outlook by Types and Applications to 2028

    • 10.1 Global Multiple Sclerosis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Injectable agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oral agents Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Multiple Sclerosis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hosptial Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Consumption Forecast and Growth Rate (2022-2028)

    11 Global Multiple Sclerosis Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Multiple Sclerosis Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Multiple Sclerosis Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Multiple Sclerosis Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Multiple Sclerosis Market Competitive Analysis

    • 14.1 Teva

      • 14.1.1 Teva Company Details

      • 14.1.2 Teva Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Multiple Sclerosis Product and Service

    • 14.2 GlaxoSmithKline

      • 14.2.1 GlaxoSmithKline Company Details

      • 14.2.2 GlaxoSmithKline Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline Multiple Sclerosis Product and Service

    • 14.3 Novartis

      • 14.3.1 Novartis Company Details

      • 14.3.2 Novartis Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis Multiple Sclerosis Product and Service

    • 14.4 Biogen

      • 14.4.1 Biogen Company Details

      • 14.4.2 Biogen Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biogen Multiple Sclerosis Product and Service

    • 14.5 Bayer HealthCare

      • 14.5.1 Bayer HealthCare Company Details

      • 14.5.2 Bayer HealthCare Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer HealthCare Multiple Sclerosis Product and Service

    • 14.6 Acorda Therapeutics

      • 14.6.1 Acorda Therapeutics Company Details

      • 14.6.2 Acorda Therapeutics Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Acorda Therapeutics Multiple Sclerosis Product and Service

    • 14.7 Abbvie

      • 14.7.1 Abbvie Company Details

      • 14.7.2 Abbvie Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Abbvie Multiple Sclerosis Product and Service

    • 14.8 Merck Serono

      • 14.8.1 Merck Serono Company Details

      • 14.8.2 Merck Serono Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck Serono Multiple Sclerosis Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Multiple Sclerosis Product and Service

    • 14.10 Genzyme (Sanofi)

      • 14.10.1 Genzyme (Sanofi) Company Details

      • 14.10.2 Genzyme (Sanofi) Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Genzyme (Sanofi) Multiple Sclerosis Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Multiple Sclerosis

    • Figure Multiple Sclerosis Picture

    • Table Global Multiple Sclerosis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Multiple Sclerosis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Multiple Sclerosis Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Multiple Sclerosis Consumption by Country (2017-2022)

    • Figure United States Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Table Europe Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure China Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Japan Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure India Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Sclerosis Consumption Forecast by Country (2022-2028)

    • Figure United States Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injectable agents Consumption and Growth Rate (2017-2022)

    • Figure Global Oral agents Consumption and Growth Rate (2017-2022)

    • Figure Global Hosptial Consumption and Growth Rate (2017-2022)

    • Figure Global Research Consumption and Growth Rate (2017-2022)

    • Figure Global Injectable agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hosptial Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Multiple Sclerosis Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Multiple Sclerosis Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Multiple Sclerosis Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Multiple Sclerosis Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Multiple Sclerosis Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Multiple Sclerosis Product and Service

    • Table Bayer HealthCare (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Multiple Sclerosis Product and Service

    • Table Acorda Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Acorda Therapeutics Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acorda Therapeutics Multiple Sclerosis Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Multiple Sclerosis Product and Service

    • Table Merck Serono (Foundation Year, Company Profile and etc.)

    • Table Merck Serono Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Serono Multiple Sclerosis Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Multiple Sclerosis Product and Service

    • Table Genzyme (Sanofi) (Foundation Year, Company Profile and etc.)

    • Table Genzyme (Sanofi) Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme (Sanofi) Multiple Sclerosis Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US